How have BTCY shares performed in 2024?

Biotricity's stock was trading at $1.15 on January 1st, 2024. Since then, BTCY stock has increased by 10.4% and is now trading at $1.27. View the best growth stocks for 2024 here .

How were Biotricity's earnings last quarter?

Biotricity, Inc. (OTCMKTS:BTCY) announced its quarterly earnings data on Tuesday, February, 20th. The company reported ($0.34) EPS for the quarter, beating analysts' consensus estimates of ($0.41) by $0.07. The firm earned $2.97 million during the quarter, compared to analyst estimates of $3 million.

When did Biotricity's stock split?

Shares of Biotricity reverse split on Monday, July 3rd 2023. The 1-6 reverse split was announced on Monday, July 3rd 2023. The number of shares owned by shareholders was adjusted after the market closes on Monday, July 3rd 2023. An investor that had 100 shares of stock prior to the reverse split would have 17 shares after the split.

What other stocks do shareholders of Biotricity own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Biotricity investors own include Axsome Therapeutics (AXSM) , Bank of America (BAC) , Sorrento Therapeutics (SRNE) , Advanced Micro Devices (AMD) , Broadcom (AVGO) , Cannabix Technologies (BLOZF) , BioLineRx (BLRX) , CV Sciences (CVSI) and Charlotte's Web (CWBHF) .

How do I buy shares of Biotricity?

Shares of BTCY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

OTCMKTS:BTCY

Biotricity (BTCY) Stock Price, News & Analysis

→ Emergency: Biden's $20 Trillion Mistake Could Cost YOU! (From GoldenCrest Metals) (Ad)

Free BTCY Stock Alerts

$1.27

+0.07 (+5.83%)

(As of 04/17/2024 ET)

Compare

Today's Range: $1.20
▼
$1.37
50-Day Range: $0.78
▼
$1.63
52-Week Range: $0.70
▼
$5.10

Volume: 102,607 shs
Average Volume: 78,880 shs
Market Capitalization: $11.96 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Chart Earnings Financials Headlines Insider Trades Ownership SEC Filings

Get Biotricity alerts:

Ad GoldenCrest Metals

Exposed: How Big Banks Plan to Chain Your Wealth with Digital Dollars

Big Banks have declared war on your wallet. But it's not too late to fight back. Discover how to protect your assets from their latest maneuver.

Learn More Now

About Biotricity Stock (OTCMKTS:BTCY)

Biotricity, Inc., a medical technology company, provides biometric data monitoring solutions in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It offers Bioflux mobile cardiac telemetry solution, an integrated ECG device; and ECG analysis software that analyzes and synthesizes patient ECG monitoring data, as well as software components. The company is based in Redwood City, California.

BTCY Stock Price History

30 days | 90 days | 365 days | Advanced Chart

BTCY Stock News Headlines

March 8, 2024 | finance.yahoo.com

Are Medical Stocks Lagging HCA Healthcare (HCA) This Year?

February 22, 2024 | morningstar.com

Biotricity Inc BTCY

April 18, 2024 | Paradigm Press (Ad)

Bitcoin Rockets To Record High But Buy THIS Instead

Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…

February 22, 2024 | benzinga.com

Biotricity Stock (NASDAQ:BTCY) Earnings Dates and Earning Calls

February 19, 2024 | benzinga.com

Biotricity's Earnings Outlook

February 19, 2024 | finance.yahoo.com

Biotricity to Host Third Quarter Fiscal Year 2024 Financial Results and Business Update Call on February 21st

February 3, 2024 | msn.com

Biotricity Inc. Faces Potential Nasdaq Delisting Threat

January 23, 2024 | finanznachrichten.de

Biotricity, Inc.: Biotricity Expands Development of its Cardiac AI Cloud Platform with Data Ecosystem of over 360 billion Heartbeats

April 18, 2024 | Paradigm Press (Ad)

Bitcoin Rockets To Record High But Buy THIS Instead

Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…

January 23, 2024 | finance.yahoo.com

Biotricity Expands Development of its Cardiac AI Cloud Platform with Data Ecosystem of over 360 billion Heartbeats

November 20, 2023 | msn.com

HC Wainwright & Co. Downgrades Biotricity (BTCY)

November 14, 2023 | msn.com

Biotricity reports Q2 results

November 13, 2023 | benzinga.com

Earnings Outlook For Biotricity

November 2, 2023 | finanznachrichten.de

Biotricity, Inc.: Biotricity Releases Another Groundbreaking Product: Biotres Pro

October 31, 2023 | finance.yahoo.com

Biotricity Releases Another Groundbreaking Product: Biotres Pro

October 10, 2023 | finanznachrichten.de

Biotricity, Inc.: Biotricity Continues to Expand Patent Portfolio with Latest Patent Filing for Bioheart Device

October 10, 2023 | finance.yahoo.com

Biotricity Continues to Expand Patent Portfolio with Latest Patent Filing for Bioheart Device

October 4, 2023 | finanznachrichten.de

Biotricity, Inc.: CORRECTION BY SOURCE: Biotricity Announces Patent Filing for Cutting-Edge Biotres Device

October 4, 2023 | finance.yahoo.com

CORRECTION BY SOURCE: Biotricity Announces Patent Filing for Cutting-Edge Biotres Device

September 29, 2023 | finance.yahoo.com

Biotricity, Inc. (NASDAQ:BTCY) Could Be Riskier Than It Looks

August 28, 2023 | usatoday.com

Why Biotricity and Waqaas Al-Siddiq are Revolutionizing Modern Healthcare

August 20, 2023 | finance.yahoo.com

Biotricity, Inc. (NASDAQ:BTCY) Q1 2024 Earnings Call Transcript

August 15, 2023 | finanznachrichten.de

Biotricity, Inc.: Biotricity Reports Strong Growth for its First Quarter Fiscal Year 2024 and Provides Financial Results and Business Updates

August 15, 2023 | finance.yahoo.com

Biotricity Reports Strong Growth for its First Quarter Fiscal Year 2024 and Provides Financial Results and Business Updates

August 14, 2023 | finance.yahoo.com

Biotricity to Host First Quarter Fiscal Year 2024 Financial Results and Business Update Call on August 15th

August 11, 2023 | finanznachrichten.de

Biotricity, Inc.: Biotricity Shows Continued Growth and Strength in its Fundamentals on its Path to Profitability

August 11, 2023 | finance.yahoo.com

Biotricity Shows Continued Growth and Strength in its Fundamentals on its Path to Profitability

See More Headlines

Receive BTCY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Biotricity and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 2/20/2024
Today: 4/18/2024
Fiscal Year End: 3/31/2025

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Sector: Medical
Industry: Medical Devices
Sub-Industry: N/A
Current Symbol: OTCMKTS:BTCY
CUSIP: N/A
CIK: 1630113
Web: www.biotricity.com
Phone: (650) 832-1626
Fax: N/A
Employees: 55
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): ($1.39)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-18,660,000.00
Net Margins: -163.11%
Pretax Margin: -163.11%
Return on Equity: N/A
Return on Assets: -252.90%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 0.29
Quick Ratio: 0.14

Sales & Book Value

Annual Sales: $11.63 million
Price / Sales: 1.03
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: ($2.67) per share
Price / Book: -0.48

Miscellaneous

Outstanding Shares: 9,420,000
Free Float: 6,963,000
Market Cap: $11.96 million
Optionable: Not Optionable
Beta: 1.51

The Next 7 Blockbuster Stocks for Growth Investors

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.

Get This Free Report

Key Executives

Dr. Waqaas Al-Siddiq Ph.D. (Age 39)
Founder, President, CEO & Chairman
Comp: $732k
Mr. S. John Ayanoglou (Age 57)
Chief Financial Officer
Comp: $305.75k
Mr. Andy Wong
Vice President of Operations
Dr. George N. Nikopoulos
Director of Business Development
Mr. Matt Zabel
Vice President of Sales & Strategy
Mr. Amir Ali
Chief Development Officer

Key Competitors

View All Competitors

BTCY Stock Analysis - Frequently Asked Questions

How have BTCY shares performed in 2024?: Biotricity's stock was trading at $1.15 on January 1st, 2024. Since then, BTCY stock has increased by 10.4% and is now trading at $1.27.
View the best growth stocks for 2024 here.
How were Biotricity's earnings last quarter?: Biotricity, Inc. (OTCMKTS:BTCY) announced its quarterly earnings data on Tuesday, February, 20th. The company reported ($0.34) EPS for the quarter, beating analysts' consensus estimates of ($0.41) by $0.07. The firm earned $2.97 million during the quarter, compared to analyst estimates of $3 million.
When did Biotricity's stock split?: Shares of Biotricity reverse split on Monday, July 3rd 2023. The 1-6 reverse split was announced on Monday, July 3rd 2023. The number of shares owned by shareholders was adjusted after the market closes on Monday, July 3rd 2023. An investor that had 100 shares of stock prior to the reverse split would have 17 shares after the split.

What other stocks do shareholders of Biotricity own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Biotricity investors own include Axsome Therapeutics (AXSM), Bank of America (BAC), Sorrento Therapeutics (SRNE), Advanced Micro Devices (AMD), Broadcom (AVGO), Cannabix Technologies (BLOZF), BioLineRx (BLRX), CV Sciences (CVSI) and Charlotte's Web (CWBHF).
How do I buy shares of Biotricity?: Shares of BTCY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:BTCY) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial